Simplex Trading’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $56.4K | Buy |
+26,000
| New | +$64.5K | ﹤0.01% | 5739 |
|
|
2025
Q4 | – | Sell |
-26,100
| Closed | -$57K | – | 9733 |
|
|
2025
Q3 | $57K | Buy |
+26,100
| New | +$42.5K | ﹤0.01% | 6323 |
|
|
2025
Q2 | – | Sell |
-500
| Closed | -$1K | – | 9504 |
|
|
2025
Q1 | $1K | Buy |
+500
| New | +$1.19K | ﹤0.01% | 8281 |
|
|
2024
Q2 | – | Sell |
-2,000
| Closed | -$2K | – | 9580 |
|
|
2024
Q1 | $2K | Buy |
+2,000
| New | +$2.99K | ﹤0.01% | 8437 |
|
|
2023
Q3 | – | Sell |
-700
| Closed | -$1K | – | 9562 |
|
|
2023
Q2 | $1K | Buy |
+700
| New | +$1.67K | ﹤0.01% | 8696 |
|
|
2023
Q1 | – | Sell |
-1,100
| Closed | -$1K | – | 9874 |
|
|
2022
Q4 | $1K | Sell |
1,100
-400
| -27% | -$439 | ﹤0.01% | 8889 |
|
|
2022
Q3 | $1K | Sell |
1,500
-88,600
| -98% | -$98.1K | ﹤0.01% | 9606 |
|
|
2022
Q2 | $98K | Sell |
90,100
-2,600
| -3% | -$3.04K | ﹤0.01% | 5580 |
|
|
2022
Q1 | $98K | Buy |
92,700
+80,200
| +642% | +$73.5K | ﹤0.01% | 6176 |
|
|
2021
Q4 | $10K | Sell |
12,500
-282,500
| -96% | -$296K | ﹤0.01% | 9043 |
|
|
2021
Q3 | $551K | Hold |
295,000
| – | – | ﹤0.01% | 3938 |
|
|
2021
Q2 | $563K | Buy |
295,000
+294,657
| +85,906% | +$1.01M | ﹤0.01% | 3958 |
|
|
2021
Q1 | $152K | Buy |
343
+243
| +243% | +$1.13K | ﹤0.01% | 5163 |
|
|
2020
Q4 | $36K | Buy |
100
+81
| +426% | +$290 | ﹤0.01% | 6503 |
|
|
2020
Q3 | $7K | Buy |
19
+9
| +90% | +$33 | ﹤0.01% | 6965 |
|
|
2020
Q2 | $3K | Buy |
+10
| New | +$34 | ﹤0.01% | 7171 |
|
|
2020
Q1 | – | Sell |
-5
| Closed | -$1K | – | 8108 |
|
|
2019
Q4 | $1K | Buy |
+5
| New | +$12 | ﹤0.01% | 7122 |
|
|
2019
Q2 | – | Sell |
-34
| Closed | -$14K | – | 7618 |
|
|
2019
Q1 | $14K | Hold |
34
| – | – | ﹤0.01% | 5947 |
|
|
2018
Q4 | $10K | Buy |
34
+3
| +10% | +$14 | ﹤0.01% | 5853 |
|
|
2018
Q3 | $22K | Buy |
+31
| New | +$156 | ﹤0.01% | 5883 |
|
|
2018
Q2 | – | Sell |
-31
| Closed | -$16K | – | 7774 |
|
|
2018
Q1 | $16K | Buy |
+31
| New | +$204 | ﹤0.01% | 3573 |
|
|
2016
Q4 | – | Sell |
-18
| Closed | -$9K | – | 6368 |
|
|
2016
Q3 | $9K | Sell |
18
-10
| -36% | -$62 | ﹤0.01% | 3707 |
|
|
2016
Q2 | $12K | Buy |
+28
| New | +$224 | ﹤0.01% | 3429 |
|
|
2015
Q4 | – | Sell |
-10
| Closed | -$8K | – | 5970 |
|
|
2015
Q3 | $8K | Buy |
10
+5
| +100% | +$79 | ﹤0.01% | 3647 |
|
|
2015
Q2 | $1K | Sell |
5
-10
| -67% | -$207 | ﹤0.01% | 4762 |
|
|
2015
Q1 | $5K | Buy |
15
+14
| +1,400% | +$274 | ﹤0.01% | 3525 |
|
|
2014
Q4 | $3K | Buy |
+1
| New | +$21 | ﹤0.01% | 3505 |
|
Other funds holding PLX
MCO
SWP
VPM
PFS
OM
Simplex Trading's PLX Position: Q1 2026 in Review
Simplex Trading opened a new position in Protalix BioTherapeutics (PLX) in Q1 2026: 22,671 shares worth $49.2K. The stake represents ﹤0.01% of the portfolio and ranks #5898 among its holdings. This is a return to the name: Simplex Trading previously reported a position in PLX as recently as Q3 2025.
Simplex Trading first reported a position in PLX in Q4 2014 and has held it in 26 quarters since. The position peaked at $197K in Q1 2021. 99 funds tracked by Wall St. Rank hold PLX as of Q1 2026.
- Simplex Trading held 22,671 shares of Protalix BioTherapeutics worth $49.2K as of Q1 2026.
- Protalix BioTherapeutics was a new Simplex Trading position in Q1 2026.
- Protalix BioTherapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #5898 holding.
- Simplex Trading first reported a position in Protalix BioTherapeutics in Q4 2014 and has held it in 26 quarters since.
- Simplex Trading's Protalix BioTherapeutics position peaked at $197K in Q1 2021.
- 99 funds tracked by Wall St. Rank held Protalix BioTherapeutics as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.